Primary Site >> Liver Cancer

Gene >> AXL

Journal: Genomics. 1998 Jun 15;50(3):331-40.
Title: Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma.
Author: Tsou, A P|Wu, K M|Tsen, T Y|Chi, C W|Chiu, J H|Lui, W Y|Hu, C P|Chang, C|Chou, C K|Tsai, S F
PMID: 9676427
Journal: Mol Carcinog. 2010 Oct;49(10):882-91.
Title: Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis.
Author: He, Ling|Zhang, Jianing|Jiang, Lili|Jin, Changgong|Zhao, Yongfu|Yang, Guang|Jia, Li
PMID: 20635370
Journal: Oncogene. 2011 Mar 10;30(10):1229-40.
Title: AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.
Author: Xu, M Z|Chan, S W|Liu, A M|Wong, K F|Fan, S T|Chen, J|Poon, R T|Zender, L|Lowe, S W|Hong, W|Luk, J M
PMID: 21076472
Journal: Biomed Pharmacother. 2012 Sep;66(6):454-8.
Title: Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells.
Author: Lin, Zu-Yau|Chuang, Wan-Long
PMID: 22681909
Journal: World J Gastroenterol. 2012 Oct 14;18(38):5369-76.
Title: Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma.
Author: Li, Ji|Jia, Li|Ma, Zhen-Hai|Ma, Qiu-Hong|Yang, Xiao-Hong|Zhao, Yong-Fu
PMID: 23082053
Journal: Adv Exp Med Biol. 2013;986:143-70.
Title: Receptor tyrosine kinases: principles and functions in glioma invasion.
Author: Nakada, Mitsutoshi|Kita, Daisuke|Teng, Lei|Pyko, Ilya V|Watanabe, Takuya|Hayashi, Yutaka|Hamada, Jun-ichiro
PMID: 22879068
Journal: Am J Pathol. 2013 Dec;183(6):1719-1730.
Title: Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
Author: Hsu, Shu-Hao|Wang, Bo|Kutay, Huban|Bid, Hemant|Shreve, Julia|Zhang, Xiaoli|Costinean, Stefan|Bratasz, Anna|Houghton, Peter|Ghoshal, Kalpana
PMID: 24113455
Journal: Carcinogenesis. 2014 Apr;35(4):769-75.
Title: Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma.
Author: Lee, Hsin-Jung|Jeng, Yung-Ming|Chen, Yu-Ling|Chung, Ling|Yuan, Ray-Hwang
PMID: 24233839
Journal: Tumour Biol. 2014 Apr;35(4):3809-17.
Title: Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway.
Author: Xu, Jingchao|Jia, Li|Ma, Hongye|Li, Yanping|Ma, Zhenhai|Zhao, Yongfu
PMID: 24347489
Journal: Exp Eye Res. 2014 Jul;124:67-73.
Title: The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
Author: Brodowska, Katarzyna|Al-Moujahed, Ahmad|Marmalidou, Anna|Meyer Zu Horste, Melissa|Cichy, Joanna|Miller, Joan W|Gragoudas, Evangelos|Vavvas, Demetrios G
PMID: 24837142
Journal: Oncol Lett. 2015 Nov;10(5):2691-2698.
Title: MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells.
Author: Li, Xiao-Yun|Wen, Jing-Yun|Jia, Chang-Chang|Wang, Tian-Tian|Li, Xing|Dong, Min|Lin, Q U|Chen, Zhan-Hong|Ma, Xiao-Kun|Wei, L I|Lin, Ze-Xiao|Ruan, Dan-Yun|Chen, Jie|Wu, Dong-Hao|Liu, Wei|Tai, Yan|Xiong, Zhi-Yong|Wu, Xiang-Yuan|Zhang, Q I
PMID: 26722228
Journal: Oncol Rep. 2015 Dec;34(6):2987-96.
Title: Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies.
Author: Fujimori, Takayuki|Kato, Kiyohito|Fujihara, Shintaro|Iwama, Hisakazu|Yamashita, Takuma|Kobayashi, Kiyoyuki|Kamada, Hideki|Morishita, Asahiro|Kobara, Hideki|Mori, Hirohito|Okano, Keiichi|Suzuki, Yasuyuki|Masaki, Tsutomu
PMID: 26398221
Journal: Int J Cancer. 2015 Jul 15;137(2):385-394.
Title: Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
Author: Reichl, Patrick|Fang, Meng|Starlinger, Patrick|Staufer, Katharina|Nenutil, Rudolf|Muller, Petr|Greplova, Kristina|Valik, Dalibor|Dooley, Steven|Brostjan, Christine|Gruenberger, Thomas|Shen, Jiayun|Man, Kwan|Trauner, Michael|Yu, Jun|Gao, Chun Fang|Mikulits
PMID: 25529751
Journal: Hepatology. 2015 Mar;61(3):759-61.
Title: When good transforming growth factor-beta turns bad in hepatocellular carcinoma: Axl takes the stage.
Author: Calvisi, Diego F
PMID: 25429775
Journal: Hepatology. 2015 Mar;61(3):930-41.
Title: Axl activates autocrine transforming growth factor-beta signaling in hepatocellular carcinoma.
Author: Reichl, Patrick|Dengler, Mirko|van Zijl, Franziska|Huber, Heidemarie|Fuhrlinger, Gerhard|Reichel, Christian|Sieghart, Wolfgang|Peck-Radosavljevic, Markus|Grubinger, Markus|Mikulits, Wolfgang
PMID: 25251599
Journal: Int J Oncol. 2016 Jan;48(1):358-66.
Title: Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression.
Author: Duan, Yan|Wong, Winnie|Chua, Sonja Courtney|Wee, Hwee Lin|Lim, Seng Gee|Chua, Boon Tin|Ho, Han Kiat
PMID: 26573872
Journal: PLoS One. 2016 May 16;11(5):e0154767.
Title: Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma.
Author: Liu, Jian|Wang, Kui|Yan, Zhenlin|Xia, Yong|Li, Jun|Shi, Lehua|Zou, Qifei|Wan, Xuying|Jiao, Binghua|Wang, Hongyang|Wu, Mengchao|Zhang, Yongjie|Shen, Feng
PMID: 27182739
Journal: Clin Cancer Res. 2017 May 15;23(10):2405-2413.
Title: A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma.
Author: Yau, Thomas C C|Lencioni, Riccardo|Sukeepaisarnjaroen, Wattana|Chao, Yee|Yen, Chia-Jui|Lausoontornsiri, Wirote|Chen, Pei-Jer|Sanpajit, Theeranun|Camp, Aaron|Cox, Donna S|Gagnon, Robert C|Liu, Yuan|Raffensperger, Kristen E|Kulkarni, Diptee A|Kallender, How
PMID: 27821605
Journal: Sci Rep. 2017 Apr 4;7(1):641.
Title: Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.
Author: Ohshima, Keiichi|Hatakeyama, Keiichi|Nagashima, Takeshi|Watanabe, Yuko|Kanto, Kaori|Doi, Yuki|Ide, Tomomi|Shimoda, Yuji|Tanabe, Tomoe|Ohnami, Sumiko|Ohnami, Shumpei|Serizawa, Masakuni|Maruyama, Koji|Akiyama, Yasuto|Urakami, Kenichi|Kusuhara, Masatoshi|Moc
PMID: 28377632
Journal: Ann Oncol. 2017 Mar 1;28(3):528-534.
Title: Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study.
Author: Kelley, R K|Verslype, C|Cohn, A L|Yang, T-S|Su, W-C|Burris, H|Braiteh, F|Vogelzang, N|Spira, A|Foster, P|Lee, Y|Van Cutsem, E
PMID: 28426123
Journal: Oncotarget. 2017 Apr 18;8(16):26434-26447.
Title: RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
Author: Wang, Wei|Jia, Wei-Dong|Hu, Bing|Pan, Yue-Yin
PMID: 28460436
Journal: Oncotarget. 2017 Jul 11;8(28):46234-46248.
Title: Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Author: Dengler, Mirko|Staufer, Katharina|Huber, Heidemarie|Stauber, Rudolf|Bantel, Heike|Weiss, Karl Heinz|Starlinger, Patrick|Pock, Hannelore|Kloters-Plachky, Petra|Gotthardt, Daniel N|Rauch, Peter|Lackner, Carolin|Stift, Judith|Brostjan, Christine|Gruenberger,
PMID: 28526812
Journal: Future Oncol. 2017 Jul 13.
Title: Cabozantinib in the treatment of hepatocellular carcinoma.
Author: B Peters, Mary Linton|Miksad, Rebecca A
PMID: 28703624
Journal: Eur J Cancer. 2017 Nov;86:296-304.
Title: Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours.
Author: Schoffski, Patrick|Gordon, Michael|Smith, David C|Kurzrock, Razelle|Daud, Adil|Vogelzang, Nicholas J|Lee, Yihua|Scheffold, Christian|Shapiro, Geoffrey I
PMID: 29059635
Journal: Cell Death Dis. 2017 Oct 26;8(10):e3135.
Title: The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.
Author: Staufer, Katharina|Dengler, Mirko|Huber, Heidemarie|Marculescu, Rodrig|Stauber, Rudolf|Lackner, Carolin|Dienes, Hans-Peter|Kivaranovic, Danijel|Schachner, Christian|Zeitlinger, Markus|Wulkersdorfer, Beatrix|Rauch, Peter|Prager, Gerhard|Trauner, Michael|Mi
PMID: 29072690
Journal: Oncol Lett. 2018 Feb;15(2):2441-2450.
Title: Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells.
Author: Scharf, Irene|Bierbaumer, Lisa|Huber, Heidemarie|Wittmann, Philipp|Haider, Christine|Pirker, Christine|Berger, Walter|Mikulits, Wolfgang
PMID: 29434956
Journal: N Engl J Med. 2018 Jul 5;379(1):54-63.
Title: Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
Author: Abou-Alfa, Ghassan K|Meyer, Tim|Cheng, Ann-Lii|El-Khoueiry, Anthony B|Rimassa, Lorenza|Ryoo, Baek-Yeol|Cicin, Irfan|Merle, Philippe|Chen, YenHsun|Park, Joong-Won|Blanc, Jean-Frederic|Bolondi, Luigi|Klumpen, Heinz-Josef|Chan, Stephen L|Zagonel, Vittorina|P
PMID: 29972759
Journal: Hepatology. 2018 Jul 16.
Title: Transforming Growth Factor-beta and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.
Author: Haider, Christine|Hnat, Julia|Wagner, Roland|Huber, Heidemarie|Timelthaler, Gerald|Grubinger, Markus|Coulouarn, Cedric|Schreiner, Wolfgang|Schlangen, Karin|Sieghart, Wolfgang|Peck-Radosavljevic, Markus|Mikulits, Wolfgang
PMID: 30014484